ITOC vs MGRX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ITOC presents a high-risk profile characterized by a Piotroski F-Score of 4/9, indicating only marginal stability amidst a catastrophic price collapse. While the company shows strong top-line revenue growth (91.60%) and exceptional short-term liquidity (Current Ratio 8.83), these are completely overshadowed by an unsustainable operating margin of -681.94%. The stock has plummeted from a 52-week high of $32.00 to $0.28, reflecting a total loss of investor confidence and a severe technical breakdown.
MGRX exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a catastrophic operating margin of -1576.40%. Despite a low Price-to-Book ratio of 0.35, the company is experiencing consistent revenue contraction (-10.30% YoY) and massive long-term value destruction, with a 5-year price decline of 99.3%. The lack of analyst coverage and bearish insider activity further signal a lack of confidence in the company's viability.
Compare Another Pair
Related Comparisons
ITOC vs MGRX: Head-to-Head Comparison
This page compares iTonic Holdings Ltd. (ITOC) and Mangoceuticals, Inc. (MGRX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.